Forecast & RatingOnly 1 analyst currently covers Virax Biolabs (VRAX.US), with a price target of $25.00 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Jun 26, 2026; this does not constitute investment advice.
Jan 9, 2026Price forecast
$25.00868.99%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met0.0%
Stock price$2.58
Avg. target$25.0
High target$25
Low target$25
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.